查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲 ELISA 診斷測試市場預測至 2030 年 - 區域分析 - 按採用、測試類型、應用程式和最終用戶
市場調查報告書
商品編碼
1494326

歐洲 ELISA 診斷測試市場預測至 2030 年 - 區域分析 - 按採用、測試類型、應用程式和最終用戶

Europe ELISA Diagnostics Tests Market Forecast to 2030 - Regional Analysis - by Adoption, Test Type, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 110 Pages | 訂單完成後即時交付

價格

2022年歐洲ELISA診斷測試市值為3.1959億美元，預計2030年將達到5.3465億美元；預計2022年至2030年複合年成長率為6.6%。

人類感染發生率的增加推動了歐洲 ELISA 診斷測試市場

根據世界衛生組織 2020 年報告，全球大部分成年人死亡是由非傳染性疾病和慢性病造成的。未來十年，這一數字預計將成長 17%。全世界大約有三分之一的人患有多種慢性疾病。此外，全球每年有 4,100 萬人死於非傳染性疾病，佔總死亡人數的 74%。此外，每年有 1,700 萬人在 70 歲前死於非傳染性疾病；低收入和中等收入國家佔這些過早死亡的 86%。每年有 1,790 萬人死於非傳染性疾病，其中心血管疾病佔死亡率的大部分。癌症、慢性呼吸道疾病和糖尿病緊隨其後。在人類中，ELISA 測試被用作檢測癌症、傳染病、自體免疫、內分泌診斷、免疫學和細胞因子、細胞黏附分子 (CAM) 等的生物標記。 ELISA 檢測有助於在診斷過程的早期階段檢測癌症，為患者提供更好的生存機會並在最初獲得適當的治療。因此，全球對 ELISA 檢測的需求很高，導致預測期內市場成長。

歐洲 ELISA 診斷測試市場概況

根據胸腔腫瘤學雜誌的報告，肺癌在德國造成顯著的發病率、死亡率和社會經濟成本。在男性中，肺癌位居第二位，僅次於心血管疾病，2020年佔全因死亡率的6.5%。位居第三。因此，隨著德國肺癌盛行率的不斷上升，在德國醫療系統中實施肺癌篩檢和診斷顯得至關重要。為了控制德國肺癌的盛行率，市場參與者專注於生產 ELISA 診斷測試。 QIAGEN NV 就是這樣的例子之一。 2021 年 5 月，QIAGEN NV 宣布推出首個 FDA 批准的伴隨診斷 (CDx) 聲稱“therascreen KRAS RGQ PCR 試劑盒”，用於識別非小細胞肺癌 (NSCLC) 患者。 therascreen KRAS 試劑盒是第一個獲得美國食品和藥物管理局 (USFDA) 上市前批准的伴隨診斷測試，用於識別 NSCLC 腫瘤組織樣本中的 KRAS G12C 突變。因此，癌症盛行率的上升，尤其是德國肺癌的盛行率，以及製造商推出的創新產品推動了德國 ELISA 診斷測試市場的成長。

歐洲 ELISA 診斷測試市場收入及 2030 年預測（百萬美元）

歐洲 ELISA 診斷測試市場細分

歐洲 ELISA 診斷測試市場根據採用情況、測試類型、應用程式、最終用戶和國家進行細分。根據採用情況，歐洲 ELISA 診斷測試市場分為人類和獸用。 2022 年，人類細分市場將佔據更大的市場佔有率。

就測試類型而言，歐洲ELISA診斷測試市場分為夾心ELISA、間接ELISA、競爭性ELISA以及多重攜帶式ELISA。 2022 年，間接 ELISA 細分市場佔據最大的市場佔有率。

根據應用，歐洲 ELISA 診斷測試市場分為自體免疫疾病、傳染病、癌症診斷、蛋白質定量等。 2022 年，傳染病領域佔據最大的市場佔有率。

按最終用戶分類，歐洲 ELISA 診斷測試市場分為醫院和診斷中心、製藥和生物技術公司、獸醫醫院和診斷實驗室等。 2022 年，醫院和診斷中心細分市場佔據最大的市場佔有率。

根據國家/地區，歐洲 ELISA 診斷測試市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。 2022 年，德國在歐洲 ELISA 診斷測試市場佔有率中佔據主導地位。

Bio-Rad Laboratories Inc.、Idex Laboratories Inc.、F. Hoffmann-La Roche Ltd.、Thermo Fisher Scientific Inc.、Abbott Laboratories、Danaher Corp.、Innovative Diagnostics SAS、DiaSorin SpA、Elabscience Biotechnology Inc. 和 Bio-Tech Dine Corp.是歐洲ELISA 診斷測試市場上的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲 ELISA 診斷測試市場 - 主要產業動態

  • 主要市場促進因素
    • 動物傳染病不斷增加
    • 人類感染發生率增加
  • 主要市場限制
    • 產品召回事件
  • 主要市場機會
    • 創新產品發布
  • 未來的趨勢
    • 基於 ELISA 的程序的進展

第 5 章：ELISA 診斷測試市場 - 歐洲市場分析

  • 概述
  • ELISA 診斷測試市場收入，2022 - 2030

第 6 章：歐洲 ELISA 診斷測試市場 - 收入和 2030 年預測 - 按採用情況

  • 概述
  • 歐洲 ELISA 診斷測試市場收入佔有率，按採用情況分類 2022 年和 2030 年 (%)
  • 人類
  • 獸醫

第 7 章：歐洲 ELISA 診斷測試市場 - 2030 年收入和預測 - 按測試類型

  • 概述
  • 2022 年和 2030 年 ELISA 診斷測試市場收入佔有率，按測試類型分類 (%)
  • 夾心ELISA
  • 間接ELISA
  • 競爭性ELISA
  • 多重攜帶式 ELISA

第 8 章：歐洲 ELISA 診斷測試市場 - 收入和 2030 年預測 - 按應用

  • 概述
  • 2022 年和 2030 年歐洲 ELISA 診斷測試市場收入佔有率，按應用分類 (%)
  • 自體免疫疾病
  • 傳染病
  • 癌症診斷
  • 蛋白質定量
  • 其他

第 9 章：歐洲 ELISA 診斷測試市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年歐洲 ELISA 診斷測試市場收入佔有率（按最終用戶分類）（%）
  • 醫院和診斷中心
  • 製藥與生物技術公司
  • 獸醫醫院和診斷實驗室
  • 其他

第 10 章：歐洲 ELISA 診斷測試市場 - 收入和 2030 年預測 - 國家分析

  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區

第 11 章：ELISA 診斷測試市場-產業格局

  • 概述
  • ELISA 診斷測試市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • Bio-Rad Laboratories Inc
  • Idexx Laboratories Inc
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc
  • Abbott Laboratories
  • Danaher Corp
  • Innovative Diagnostics SAS
  • DiaSorin SpA
  • Elabscience Biotechnology Inc
  • Bio-Techne Corp

第 13 章：附錄

Product Code: BMIRE00029815

The Europe ELISA diagnostics tests market was valued at US$ 319.59 million in 2022 and is expected to reach US$ 534.65 million by 2030; it is estimated to grow at a CAGR of 6.6% from 2022 to 2030.

Increasing Incidence of Human Infections Fuels Europe ELISA Diagnostics Tests Market

According to the WHO Report 2020, noncommunicable and chronic diseases cause the majority of adult deaths worldwide. Over the next ten years, this number is expected to rise by 17%. Roughly one in three persons worldwide deal with several chronic illnesses. Moreover, noncommunicable illnesses account for 41 million annual deaths worldwide, or 74% of all fatalities. Further, 17 million individuals die from NCDs before they become 70 years old every year; low- and middle-income nations account for 86% of these premature fatalities. With 17.9 million fatalities from NCDs each year, cardiovascular illnesses account for the majority of mortality. Cancer, chronic respiratory diseases, and diabetes follow closely behind. In humans, ELISA test is used as a biomarker to detect cancer, infectious diseases, autoimmunity, endocrinology diagnosis, immunology & cytokines, cell adhesion molecules (CAMs), and others. ELISA testing helps detect cancer at the early stage of diagnostic processes, offering a better chance for patient survival and getting appropriate treatment initially. Therefore, demand for ELISA testing is high across the world owing resulting in market growth during the forecast period.

Europe ELISA Diagnostics Tests Market Overview

According to the Journal of Thoracic Oncology report, lung cancer is responsible to cause significant morbidity, mortality, and socioeconomic cost in Germany. In men, lung cancer ranks second after cardiovascular disease, accounting for 6.5% of all-cause mortality in 2020. With an age-standardized incidence rate of 32.7 and 52.1 (per 100,000) in men and women, respectively, lung cancer ranked third in women and second in men in Germany. Therefore, with the rising prevalence of lung cancer in the country, the implementation of lung cancer screening and diagnosis in the German healthcare system is of utmost importance. To control the prevalence of lung cancer in Germany, market players focus on manufacturing ELISA diagnostic tests. QIAGEN N.V. is one such example. In May 2021, QIAGEN N.V. announced the launch of its first FDA-approved companion diagnostic (CDx) claims for the "therascreen KRAS RGQ PCR Kit" to identify non-small cell lung cancer (NSCLC) patients. The therascreen KRAS kit is the first companion diagnostic test to obtain premarket approval from the US Food and Drug Administration (USFDA) to identify the KRAS G12C mutation in samples of NSCLC tumor tissues. Therefore, the rising cancer prevalence, particularly lung cancer in Germany, and innovative product launches by the manufacturers boost the ELISA diagnostic test market growth in Germany.

Europe ELISA Diagnostics Tests Market Revenue and Forecast to 2030 (US$ Million)

Europe ELISA Diagnostics Tests Market Segmentation

The Europe ELISA diagnostics tests market is segmented based on adoption, test type, application, end user, and country. Based on adoption, the Europe ELISA diagnostics tests market is bifurcated into human and veterinary. The human segment held a larger market share in 2022.

In terms of test type, the Europe ELISA diagnostics tests market is segmented into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held the largest market share in 2022.

Based on application, the Europe ELISA diagnostics tests market is segmented into autoimmune diseases, infectious diseases, cancer diagnosis, protein quantification, and others. The infectious diseases segment held the largest market share in 2022.

By end user, the Europe ELISA diagnostics tests market is segmented into hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories, and others. The hospitals & diagnostic centers segment held the largest market share in 2022.

Based on country, the Europe ELISA diagnostics tests market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe ELISA diagnostics tests market share in 2022.

Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corp., Innovative Diagnostics SAS, DiaSorin SpA, Elabscience Biotechnology Inc., and Bio-Techne Corp are some of the leading companies operating in the Europe ELISA diagnostics tests market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation
    • 1.2.1 Europe ELISA Diagnostic Tests Market - by Adoption
    • 1.2.2 Europe ELISA Diagnostic Tests Market - by Test Type
    • 1.2.3 Europe ELISA Diagnostic Tests Market - by Application
    • 1.2.4 Europe ELISA Diagnostic Tests Market - by End User
    • 1.2.5 Europe ELISA Diagnostic Tests Market - by Country

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe ELISA Diagnostic Test Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Rising Infectious Diseases Among Animals
    • 4.1.2 Increasing Incidence of Human Infections
  • 4.2 Key Market Restraints
    • 4.2.1 Incidents of Product Recalls
  • 4.3 Key Market Opportunities
    • 4.3.1 Innovative Product Launches
  • 4.4 Future Trends
    • 4.4.1 Advancements in ELISA-Based Procedures

5. ELISA Diagnostic Tests Market - Europe Market Analysis

  • 5.1 Overview
  • 5.2 ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 - 2030

6. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Adoption

  • 6.1 Overview
  • 6.2 Europe ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
  • 6.3 Human
    • 6.3.1 Overview
    • 6.3.2 Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Veterinary
    • 6.4.1 Overview
    • 6.4.2 Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 Sandwich ELISA
    • 7.3.1 Overview
    • 7.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Indirect ELISA
    • 7.4.1 Overview
    • 7.4.2 Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Competitive ELISA
    • 7.5.1 Overview
    • 7.5.2 Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Multiple & Portable ELISA
    • 7.6.1 Overview
    • 7.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Europe ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Autoimmune Diseases
    • 8.3.1 Overview
    • 8.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Infectious Disease
    • 8.4.1 Overview
    • 8.4.2 Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Cancer Diagnosis
    • 8.5.1 Overview
    • 8.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Protein Quantification
    • 8.6.1 Overview
    • 8.6.2 Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Europe ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals & Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Pharmaceutical & Biotechnology Companies
    • 9.4.1 Overview
    • 9.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Veterinary Hospitals & Diagnostic Laboratories
    • 9.5.1 Overview
    • 9.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 Europe: ELISA Diagnostic Tests Market
    • 10.1.1 Europe: ELISA Diagnostic Tests Market, by Country
      • 10.1.1.1 Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 Germany: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 10.1.1.1.4 Germany: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.1.5 Germany: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.1.6 Germany: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.2 France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 France: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 10.1.1.2.4 France: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.5 France: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.2.6 France: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.3 UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 UK: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 10.1.1.3.4 UK: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.3.5 UK: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.3.6 UK: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.4 Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.3 Italy: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 10.1.1.4.4 Italy: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.4.5 Italy: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.4.6 Italy: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.5 Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.3 Spain: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 10.1.1.5.4 Spain: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.5.5 Spain: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.5.6 Spain: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.6 Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 10.1.1.6.4 Rest of Europe: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.6.5 Rest of Europe: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.6.6 Rest of Europe: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)

11. ELISA Diagnostics Test Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in ELISA diagnostics test Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Bio-Rad Laboratories Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Idexx Laboratories Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 F. Hoffmann-La Roche Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Thermo Fisher Scientific Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Abbott Laboratories
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Danaher Corp
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Innovative Diagnostics SAS
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 DiaSorin SpA
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Elabscience Biotechnology Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Financial Overview
    • 12.9.4 SWOT Analysis
    • 12.9.5 Key Developments
  • 12.10 Bio-Techne Corp
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. ELISA Diagnostic Test Market Segmentation
  • Table 2. SARS-CoV-2 Product Launches by Manufacturers Amid COVID-19 Pandemic
  • Table 3. Germany ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Germany ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Germany ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Germany ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. France ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. France ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. France ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. France ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. UK ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. UK ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. UK ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. UK ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Italy ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Italy ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Italy ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Italy ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Spain ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Spain ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Spain ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Spain ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Rest of Europe ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Rest of Europe ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Rest of Europe ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Rest of Europe ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Recent Organic Growth Strategies in ELISA diagnostics Test Market
  • Table 28. Recent Inorganic Growth Strategies in the ELISA diagnostics Test Market
  • Table 29. Glossary of Terms, ELISA Diagnostic Tests Market

List Of Figures

  • Figure 1. ELISA Diagnostic Test Market Segmentation, By Country
  • Figure 2. ELISA Diagnostic Test Market: Key Industry Dynamics
  • Figure 3. ELISA Diagnostic Tests Market: Impact Analysis of Drivers and Restraints
  • Figure 4. ELISA Diagnostic Tests Market Revenue (US$ Mn), 2021 - 2030
  • Figure 5. Europe ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
  • Figure 6. Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 9. Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Europe ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 14. Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Europe ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 20. Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Europe: ELISA Diagnostic Tests Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 25. Europe: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
  • Figure 26. Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Growth Strategies in ELISA diagnostics test Market